SC
INSP icon

Swan Capital’s Inspire Medical Systems INSP Stock Holding History

Swan Capital’s Portfolio INSP Stock Details INSP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$268 Hold
6
– – ﹤0.01% 545
2026
Q1 		$309 Hold
6
– – ﹤0.01% 510
2025
Q4 		$553 Buy
+6
New +$574 ﹤0.01% 445

Other funds holding INSP

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Nomura Holdings
Nomura Holdings Tokyo, Japan $85.4B AUM 91.09% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Swan Capital's INSP Position: Q2 2026 in Review

Swan Capital held its Inspire Medical Systems (INSP) position steady in Q2 2026 at 6 shares worth $268. The position accounts for ﹤0.01% of the portfolio, ranked #545.

Swan Capital first reported a position in INSP in Q4 2025 and has held it in 3 quarters since. The position peaked at $553 in Q4 2025. 276 funds tracked by Wall St. Rank hold INSP as of Q2 2026.

  • Swan Capital held 6 shares of Inspire Medical Systems worth $268 as of Q2 2026.
  • Swan Capital left its Inspire Medical Systems share count unchanged in Q2 2026.
  • Inspire Medical Systems made up ﹤0.01% of Swan Capital's portfolio in Q2 2026, its #545 holding.
  • Swan Capital first reported a position in Inspire Medical Systems in Q4 2025 and has held it in 3 quarters since.
  • Swan Capital's Inspire Medical Systems position peaked at $553 in Q4 2025.
  • 276 funds tracked by Wall St. Rank held Inspire Medical Systems as of Q2 2026.

Based on Swan Capital's 13F filing for Q2 2026, filed 13 Aug 2026.